InfuSystem Holdings Announces Expiration of Warrants
MADISON HEIGHTS, Mich., April 12, 2011 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE Amex:INFU), the leading provider of infusion pumps and associated products and services in the U.S. and Canada has announced today that all 9,472,496 outstanding warrants to acquire shares of its common stock have expired in accordance with their terms on April 11, 2011 and are no longer outstanding. The warrants had been issued in connection with the Company's initial public offering of common stock units (and in certain private placements in the year after the initial public offering). As of April 12, 2011, the Company's capital structure consists of 21,056,133 shares of Common Stock issued and outstanding.
InfuSystem is a leading provider of ambulatory infusion pumps to the outpatient oncology market as well as new and pre-owned infusion pumps and other biomedical equipment, and biomedical recertification, maintenance and repair services to hospitals, oncology practices and other alternate site health care providers. Headquartered in Madison Heights, Michigan, InfuSystem delivers local, field-based customer support and operates Biomedical Service Centers of Excellence in Kansas City, Los Angeles and Toronto.
CONTACT: Investor Contact:
Pat LaVecchia
info@infusystem.com
Tel: (800) 962-9656
Media Contact:
David Haar
info@infusystem.com
Tel: (800) 962-9656
Source: InfuSystem, Inc.
Recent INFU News
- InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024 • Business Wire • 05/02/2024 08:30:00 PM
- InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K • Business Wire • 04/03/2024 10:30:00 AM
- InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023 • Business Wire • 03/14/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 11:31:20 AM
- InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024 • Business Wire • 03/08/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:00:52 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:29:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:51:18 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/29/2023 10:08:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 09:30:42 PM
- InfuSystem to Present at Sidoti Small-Cap Virtual Conference on December 6, 2023 • Business Wire • 11/28/2023 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:01:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:39:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:16:50 PM
- InfuSystem to Participate at 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023 • Business Wire • 11/09/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 11:31:00 AM
- InfuSystem Reports Third Quarter 2023 Financial Results • Business Wire • 11/07/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 10:41:12 AM
- InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023 • Business Wire • 10/31/2023 10:30:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 09:51:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 09:17:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 10:38:58 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM